HENNIG ARZNEIMITTEL GmbH & Co. KG

HENNIG ARZNEIMITTEL GmbH & Co. KG is a mid-sized family-owned German pharmaceutical company with 120 years of experience. The company offers proprietary drugs in the vertigo and disturbances of equilibrium sector, where it is the market leader. Additionally, HENNIG Arzneimittel manufactures a wide range of generics, including all generically available antivertigo products, as well as cardiovascular, metabolism, pain, neurologic, and psychiatric products. The company is also rapidly expanding its portfolio to include over-the-counter drugs, devices, and food supplements, emphasizing its consumer-oriented approach. Furthermore, HENNIG Arzneimittel provides contract manufacturing and contract development services for pharmaceuticals and food supplements, specializing in complex solid dosage forms for modified release. The company's technologies encompass a variety of processes, from tableting and coating to pelletising and capsule filling, allowing for easy scale-up from lab to industrial scale. With a team of approximately 320 employees, including 90 sales reps, HENNIG Arzneimittel is well-positioned to continue its growth and innovation in the Biotechnology, Health Care, and Pharmaceutical industries. Founded in 1898, the company presents an attractive opportunity for potential investors seeking to participate in the pharmaceutical and biotechnology sectors.